- General info
- Available languages
- Background story
Supports up to 66 languages.
Please select a format to view the available languages:
Supports up to 24 OpenType features.
Please select a format to view the available OpenType features:
The Englishman William Caslon punchcut many roman, italic, and non-Latin typefaces from 1720 until his death in 1766. At that time most types were being imported to England from Dutch sources, so Caslon was influenced by the characteristics of Dutch types. He did, however, achieve a level of craft that enabled his recognition as the first great English punchcutter. Caslon's roman became so popular that it was known as the script of kings, although on the other side of the political spectrum (and the ocean), the Americans used it for their Declaration of Independence in 1776. The original Caslon specimen sheets and punches have long provided a fertile source for the range of types bearing his name. Identifying characteristics of most Caslons include a cap A with a scooped-out apex; a cap C with two full serifs; and in the italic, a swashed lowercase v and w. Caslon's types have achieved legendary status among printers and typographers, and are considered safe, solid, and dependable.
Carol Twombly designed this Caslon revival for Adobe in 1990, after studying Caslon's own specimen sheets from the mid-eighteenth century. This elegant version is quite true to the source, and has been optimized for the demands of digital design and printing. Adobe Caslon™ makes an excellent text font and includes just about everything needed by the discriminating typographer: small caps, Old style Figures, swash letters, alternates, ligatures, expert characters, central European characters, and a plethora of period ornaments.
Download a free trial
Use this font in your own documents with a free 5 minute trial through SkyFonts. Trials are for evaluation purposes only. Learn more.
This font is currently not available.
You already tried this font within the last 24 hours or you may have exceeded your daily allowance of trials. Learn more.